HOME >> MEDICINE >> NEWS
Even in an era of HAART Drugs, HIV patients are vulnerable to opportunistic infections

line therapy. They may not be effective, however, in patients who have previously had treatment with this class of drugs. Patients who are responding to HAART may be doing well enough that they don't need prophylaxis, she said.

"The risks versus benefits must be carefully evaluated. We want to protect patients from MAC, but we also want to prevent them from developing resistance to antibiotics," said Aberg, who is a UCSF assistant professor of medicine and also treats patients at San Francisco General.

In the pre-HAART era, macrolides were standard treatment as prevention therapy against MAC infection in AIDS patients whose CD4+ counts were below 75, according to Aberg. Now with HAART, many patients may have CD4+ counts that are higher.

The main conclusion from study findings, she said, is that careful consideration should be given to continuing use of macrolides for MAC prophylaxis when CD4+ counts have increased and to using macrolides for infection treatment if a patient has been on a macrolide previously.

Both research studies were supported by grants from the NIH UCSF Center for AIDS Research and the UC Universitywide AIDS Research Program,

In addition, the CMV retinitis study received a grant from Research to Prevent Blindness, Inc., and the macrolide bacterial resistance study received support from Abbott Laboratories.


'"/>

Contact: Corinna Kaarlela
ckaarlela@pubaff.ucsf.edu
415-476-3804
University of California - San Francisco
27-Sep-1999


Page: 1 2 3

Related medicine news :

1. Most episodes of HIV blips not clinically significant in patients receiving HAART
2. Multiple characteristics of HAART affect adherence
3. Researchers examine the use of antiretroviral therapy among injection drug users with HIV infection: Study suggests addiction treatment and health care contribute to HAART enrollment
4. ICAAC highlight: MAC prophylaxis can be safely discontinued in HIV-infected patients who respond to HAART
5. Old Drugs, New Tricks
6. Hormonal treatment improves survival in high-risk prostate cancer patients
7. Study finds that coordinating care of chronically ill patients does not increase liability
8. Mouse model reveals potential way to reduce cardiac deaths in kidney patients
9. Optical technique identifies vulnerable plaques in cardiac patients
10. NHS target driven culture is failing patients
11. Cardiac deaths peak in sleep hours for patients with sleep apnea

Post Your Comments:
(Date:8/5/2015)... , ... August 05, 2015 , ... Social Security benefits ... participating in a new survey by The Senior Citizens League (TSCL). The ... trouble for an estimated 31 million Social Security beneficiaries age 65 and older, says ...
(Date:8/5/2015)... ... August 05, 2015 , ... ... the testosterone multidistrict litigation known as Testosterone Replacement Therapy Products Liability Litigation, MDL ... of Illinois. The Motion to Dismiss was filed by the defendants, who include ...
(Date:8/5/2015)... ... August 05, 2015 , ... Stelari introduces their new ... yoga wear with their new line, The Earth’s Song. Combining fashion and activewear, Stelari’s ... your workout. Inspired by the Australian Outback, this collection is sure to make the ...
(Date:8/5/2015)... , ... August 05, 2015 , ... " Wildflower Seed ... Report, which takes a look small, medium, and large businesses making an impact in ... business review and shared with viewers how their gardening tools are specifically designed for ...
(Date:8/5/2015)... Palm Coast, Florida (PRWEB) , ... August 05, 2015 , ... ... Inc (CEC) is excited to announce that it has hired Su Barnwell as ... medical education program and faculty management. From 1999 to 2015 she worked for Primary ...
Breaking Medicine News(10 mins):Health News:Majority of Older Americans Say Social Security Benefits Not Keeping up with Rising Household Costs, According to a New Survey from the Senior Citizens League 2Health News:Majority of Older Americans Say Social Security Benefits Not Keeping up with Rising Household Costs, According to a New Survey from the Senior Citizens League 3Health News:Testosterone Lawsuit News: Defendants Push Back Against RICO Claim 2Health News:Testosterone Lawsuit News: Defendants Push Back Against RICO Claim 3Health News:Testosterone Lawsuit News: Defendants Push Back Against RICO Claim 4Health News:Stelari: Bohemian Chic Activewear Line 2Health News:Stelari: Bohemian Chic Activewear Line 3Health News:Wildflower Seed & Tool Company Design Gardening Tools Specifically for Women 2Health News:Leading Continuing Medical Education (CME) Provider, Continuing Education Company (CEC), hires expert Su Barnwell as Director of Program Management 2Health News:Leading Continuing Medical Education (CME) Provider, Continuing Education Company (CEC), hires expert Su Barnwell as Director of Program Management 3
(Date:8/5/2015)... 2015  Butterfly Network was awarded today as ... Pioneers for 2015.  The company is democratizing medical ... surgery. By integrating its novel imaging platform with ... a virtuous cycle, learning as they image, and ... was chosen by a professional jury among hundreds ...
(Date:8/5/2015)... BANGALORE , August 5, 2015 ... Ampoules and Blister Packaging Market segmented by Packaging ... Blister (PP, PET, PVC) - By Geographical Region ( ... , APAC, Middle East & ... Profiles, Global Market Size, Forecasts & Analysis (2015-2020). ...
(Date:8/4/2015)... Aug. 5, 2015 Karuna Pharmaceuticals, Inc. ... developing a novel product candidate for the treatment ... a Translation Fund Award from the Wellcome Trust ... up to $3.84 million. The funding, along with ... Karuna,s lead program KarXT, a potentially innovative therapy ...
Breaking Medicine Technology:Butterfly Network Recognized as a Technology Pioneer by the World Economic Forum 2DuPont, Mitsubishi Chemical Holdings and Amcor Among Other Organizations are Expected to Invest in the Asia-Pacific and Latin American Ampoules Packaging Market 2DuPont, Mitsubishi Chemical Holdings and Amcor Among Other Organizations are Expected to Invest in the Asia-Pacific and Latin American Ampoules Packaging Market 3Karuna Receives Wellcome Trust Award to Advance Innovative Clinical Stage Product Candidate for the Treatment of Schizophrenia 2Karuna Receives Wellcome Trust Award to Advance Innovative Clinical Stage Product Candidate for the Treatment of Schizophrenia 3Karuna Receives Wellcome Trust Award to Advance Innovative Clinical Stage Product Candidate for the Treatment of Schizophrenia 4
Cached News: